Want to see HK:6990 full AI Analyst Report?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Revenue
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Revenue
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H had a revenue of 489.17M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 2.20B, Increased 0.64%. In the fiscal year ending Dec 31, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H had annual revenue of 2.06B with 6.46% growth.
- Revenue (ttm)
- 2.20B
- Revenue Growth
- 43.88%
- P/S Ratio
- 49.34
- Revenue/Employee
- HKD 894,748
- Employees
- 2,300
- Market Cap
- HKD 101.54B
Revenue Chart
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06B | 124.88M | 6.46% |
| Dec 31, 2024 | 1.93B | 392.55M | 25.48% |
| Dec 31, 2023 | 1.54B | 736.56M | 91.62% |
| Dec 31, 2022 | 803.93M | 772.14M | 2428.56% |
| Dec 31, 2021 | 31.79M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.